Yingjie Zhang
+
Gender:Male
Education Level:Postgraduate (Doctoral)
Alma Mater:山东大学
Paper Publications
- [101] 徐文方 and Yingjie Zhang. Design, Synthesis, and Antitumor Evaluation of 4？Amino-2 (1H)？pyrazole Derivatives as JAKs Inhibitors. ACS Med. Chem. Lett., 2016.
- [102] 徐文方 and Yingjie Zhang. PXD101 analogs with L-phenylglycine-containing branched cap as histone deacetylase inhibitors. Chem. Biol. Drug Des., 2016.
- [103] 徐文方 and Yingjie Zhang. Design, Synthesis and Biological Evaluation of Novel Tamibarotene Derivative as Multitarget Anticancer Agent. Lett. Drug Des. Discov., 2016.
- [104] 徐文方 and Yingjie Zhang. Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent. Eur. J. Med. Chem., 2016.
- [105] 徐文方 and Yingjie Zhang. Design, synthesis and preliminary biological evaluation of 4-aminopyrazole derivatives as novel and potent JAKs inhibitors. Bioorg. Med. Chem., 2016.
- [106] 徐文方 and Yingjie Zhang. Discovery of Multi-target Anticancer Agents Based on HDAC Inhibitor MS-275 and 5-FU. Med. Chem., 2016.
- [107] Yingjie Zhang. Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation. Eur. J. Med. Chem., 2016.
- [108] 徐文方 and Yingjie Zhang. Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity. Eur. J. Med. Chem., 2015.
- [109] 徐文方 and Yingjie Zhang. Design, synthesis, and antitumor evaluation of histone deacetylase inhibitors with L-phenylglycine scaffold. Drug Des. Dev. Ther., 2015.
- [110] 张彩 and Yingjie Zhang. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by induction p21WAF1 expression and cell cycle arrest. Anti-Cancer Drugs, 2014.